MSACL 2017 US Abstract

Where the Rubber Meets the Road: Clinical Mass Spectrometry Case Studies

Matthew Feldhammer (Presenter)
Emory University

Bio: Dr. Feldhammer received his PhD. in Biochemistry at McGill University, Montreal Canada where he focused his research on developing novel immunotherapy options aimed at reactivating the immune system in pancreatic cancer patients. He is currently pursuing fellowship training in Clinical Chemistry in the Department of Pathology and Laboratory Medicine at Emory University, Atlanta under the guidance of Dr. James Ritchie and Dr. David Koch. Dr. Feldhammer has developed several assays for the clinical laboratory including the detection of nicotine and its metabolites by LC-MS/MS and most recently a molecular diagnostic method for detection of the Zika virus.

Authorship: Matthew Feldhammer (1), Alec Saitman (2)
(1) Emory University, Department of Pathology and Laboratory Medicine, (2) Providence Regional Laboratories

Short Abstract

This talk in the fundamentals of Mass spectrometry beginners track will explore how mass spectrometry is utilized in the clinical laboratory to provide actionable clinical information to healthcare providers. This session will highlight the power of mass spectrometry to resolve discrepancies and false results that can occur in traditional immunometric based platforms and provide a barrier to patient health. By exploring several real world case studies we will demonstrate how mass spectrometry is quickly becoming the gold standard platform for the modern clinical laboratory alleviating many of the inconsistencies that have plagued the laboratory medicine community in the past.

Long Abstract

This talk in the fundamentals of Mass spectrometry beginners track will explore how mass spectrometry is utilized in the clinical laboratory to provide actionable clinical information to healthcare providers. This session will highlight the power of mass spectrometry to resolve discrepancies and false results that can occur in traditional immunometric based platforms and provide a barrier to patient health. By exploring several real world case studies we will demonstrate how mass spectrometry is quickly becoming the gold standard platform for the modern clinical laboratory alleviating many of the inconsistencies that have plagued the laboratory medicine community in the past.


References & Acknowledgements:


Financial Disclosure

DescriptionY/NSource
Grantsno
Salaryyes
Board Memberno
Stockno
Expensesno

IP Royalty: no

Planning to mention or discuss specific products or technology of the company(ies) listed above:

no